Article URL: https://www.businesswire.com/news/home/20240307733599/en/MindMed-Receives-FDA-Breakthrough-Therapy-Designation-and-Announces-Positive-12-Week-Durability-Data-From-Phase-2B-Study-of-MM120-for-Generalized-Anxiety-Disorder Comments URL: https://news.ycombinator.com/item?id=39653125 Points: 36 # Comments: 4
